Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Drug Manufacturers
Hikal Ltd (BOM:524735) Q4 2024 Earnings Call Transcript Highlights: Strong Sequential Growth Amid Industry Challenges
Hikal Ltd (BOM:524735) reports a 15% sequential revenue increase and a 45% rise in EBITDA for Q4 FY24, despite facing headwinds in the crop protection sector. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Sun Pharmaceuticals Industries Ltd (BOM:524715) Q1 2025 Earnings Call Transcript Highlights: Strong Growth in India and Specialty Sales Amid US Decline
Sun Pharmaceuticals Industries Ltd (BOM:524715) reports robust Q1 FY25 performance with significant YoY profit growth despite challenges in the US market. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Caplin Point Laboratories Ltd (BOM:524742) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue and PAT Growth Amid Strategic Expansions
Caplin Point Laboratories Ltd (BOM:524742) reports robust financial performance with a 17% revenue increase and strategic plans for new product launches in the U.S. market. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Hikal Ltd (BOM:524735) Q1 2025 Earnings Call Transcript Highlights: Strong EBITDA Growth Amid Industry Challenges
Hikal Ltd (BOM:524735) reports a 16% year-on-year EBITDA growth, despite facing competitive pressures and subdued demand in the crop protection segment. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Caplin Point Laboratories Ltd (BOM:524742) Q3 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and Strategic Expansion
Caplin Point Laboratories Ltd (BOM:524742) reports a 15% increase in sales and significant progress in geographical expansion and product filings. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Hester Biosciences Ltd (BOM:524669) Q3 2024 Earnings Call Transcript Highlights: Mixed Performance Amid Regulatory and Market Challenges
Despite notable growth in certain divisions, Hester Biosciences Ltd faces revenue declines and losses in key areas. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Neuland Laboratories Ltd (BOM:524558) Q1 2025 Earnings Call Transcript Highlights: Strong Financial Performance and Strategic Insights
Neuland Laboratories Ltd (BOM:524558) reports robust growth in total income and profit, while addressing future challenges and strategic initiatives. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Hester Biosciences Ltd (BOM:524669) Q1 2025 Earnings Call Transcript Highlights: Strong Growth in Animal and Poultry Divisions Amid Overall Sales Dip
Despite a 9% overall sales decrease, Hester Biosciences Ltd (BOM:524669) reports significant growth in key divisions and a 30% profit increase for Hester India. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Hester Biosciences Ltd (BOM:524669) Q4 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Advancements
Hester Biosciences Ltd (BOM:524669) reports robust financial performance with significant revenue growth and strategic debt reduction in Q4 2024. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Ipca Laboratories Ltd (BOM:524494) Q1 2025 Earnings Call Transcript Highlights: Strong Domestic Growth Amid Export Challenges
Ipca Laboratories Ltd (BOM:524494) reports robust domestic formulation growth and improved market share, despite facing export and API business declines. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Ipca Laboratories Ltd (BOM:524494) Q3 2024 Earnings Call Transcript Highlights: Strong Domestic Growth and Improved Margins Amid Export Challenges
Ipca Laboratories Ltd (BOM:524494) reports robust domestic performance and margin improvements, despite facing hurdles in export markets. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Neuland Laboratories Ltd (BOM:524558) Q3 2024 Earnings Call Transcript Highlights: Strong Financial Performance and Strategic Investments
Neuland Laboratories Ltd (BOM:524558) reports significant growth in income and profitability, with strategic investments paving the way for future expansion. Sep 13, 2024